{"altmetric_id":10121340,"counts":{"readers":{"mendeley":74,"citeulike":0,"connotea":0},"total":{"posts_count":34},"news":{"unique_users_count":1,"unique_users":["medpage_today"],"posts_count":1},"twitter":{"unique_users_count":27,"unique_users":["LancetRespirMed","banavarrete","vinitfll","efrasanchez","pkell7","sarcybint","ild_inn","respandsleepjc","thelungdr","hswapnil","GeriMedJC","RheumJC","GarchaMed","miguelabad67","anafcruz00","DrSimply","Rheuma_suffolk","k_masuko","pkiely500","IlindelatorreMD","sergiobarbaecua","reumacia","MedReuma","Artritis_Celso","guillem89","Aenima666","UMIPIC"],"posts_count":31},"facebook":{"unique_users_count":1,"unique_users":["566682420016754"],"posts_count":1},"f1000":{"unique_users_count":1,"unique_users":["F1000Prime"],"posts_count":1}},"selected_quotes":["Mycophenolate mofetil vs cyclophosphamide in scleroderma-related interstitial lung disease htt\u2026","Next #rsjc is Thurs Aug 11th@ 7pm EDT- MMF vs cyclophosphamide for tx of Scleroderma-induced ILD","Dont forget to join us this THURS AUG 11 @ 7pm for #rsjc-MMF vs cyclophosphamide (CP) for tx of Scleroderma-ILD",". @RheumJC- join us this thurs at 7pm EDT; discussn of CP 4 tx of Scleroderma-induced ILD for #rsjc","Estudios CFM versus MFM en afectaci\u00f3n intersticial pulmonar de #esclerodermia"],"citation":{"abstract":"12 months of oral cyclophosphamide has been shown to alter the progression of scleroderma-related interstitial lung disease when compared with placebo. However, toxicity was a concern and without continued treatment the efficacy disappeared by 24 months. We hypothesised that a 2 year course of mycophenolate mofetil would be safer, better tolerated, and produce longer lasting improvements than cyclophosphamide.\nThis randomised, double-blind, parallel group trial enrolled patients from 14 US medical centres with scleroderma-related interstitial lung disease meeting defined dyspnoea, pulmonary function, and high-resolution CT (HRCT) criteria. The data coordinating centre at the University of California, Los Angeles (UCLA, CA, USA), randomly assigned patients using a double-blind, double-dummy, centre-blocked design to receive either mycophenolate mofetil (target dose 1500 mg twice daily) for 24 months or oral cyclophosphamide (target dose 2\u00b70 mg\/kg per day) for 12 months followed by placebo for 12 months. Drugs were given in matching 250 mg gel capsules. The primary endpoint, change in forced vital capacity as a percentage of the predicted normal value (FVC %) over the course of 24 months, was assessed in a modified intention-to-treat analysis using an inferential joint model combining a mixed-effects model for longitudinal outcomes and a survival model to handle non-ignorable missing data. The study was registered with ClinicalTrials.gov, number NCT00883129.\nBetween Sept 28, 2009, and Jan 14, 2013, 142 patients were randomly assigned to either mycophenolate mofetil (n=69) or cyclophosphamide (n=73). 126 patients (mycophenolate mofetil [n=63] and cyclophosphamide [n=63]) with acceptable baseline HRCT studies and at least one outcome measure were included in the primary analysis. The adjusted % predicted FVC improved from baseline to 24 months by 2\u00b719 in the mycophenolate mofetil group (95% CI 0\u00b753-3\u00b784) and 2\u00b788 in the cyclophosphamide group (1\u00b719-4\u00b758). The course of the % FVC did not differ significantly between the two treatment groups based on the prespecified primary analysis using a joint model (p=0\u00b724), indicating that the trial was negative for the primary endpoint. However, in a post-hoc analysis of the primary endpoint, the within-treatment change from baseline to 24 months derived from the joint model showed that the % FVC improved significantly in both the mycophenolate mofetil and cyclophosphamide groups. 16 (11%) patients died (five [7%] mycophenolate mofetil and 11 [15%] cyclophosphamide), with most due to progressive interstitial lung disease. Leucopenia (30 patients vs four patients) and thrombocytopenia (four vs zero) occurred more often in patients given cyclophosphamide than mycophenolate mofetil. Fewer patients on mycophenolate mofetil than on cyclophosphamide prematurely withdrew from study drug (20 vs 32) or met prespecified criteria for treatment failure (zero vs two). The time to stopping treatment was shorter in the cyclophosphamide group (p=0\u00b7019).\nTreatment of scleroderma-related interstitial lung disease with mycophenolate mofetil for 2 years or cyclophosphamide for 1 year both resulted in significant improvements in prespecified measures of lung function over the 2 year course of the study. Although mycophenolate mofetil was better tolerated and associated with less toxicity, the hypothesis that it would have greater efficacy at 24 months than cyclophosphamide was not confirmed. These findings support the potential clinical effectiveness of both cyclophosphamide and mycophenolate mofetil for progressive scleroderma-related interstitial lung disease, and the present preference for mycophenolate mofetil because of its better tolerability and toxicity profile.\nNational Heart, Lung and Blood Institute, National Institutes of Health; with drug supply provided by Hoffmann-La Roche and Genentech.","altmetric_jid":"5225ebc63cf058256d000000","authors":["Donald P Tashkin","Michael D Roth","Philip J Clements","Daniel E Furst","Dinesh Khanna","Eric C Kleerup","Jonathan Goldin","Edgar Arriola","Elizabeth R Volkmann","Suzanne Kafaja","Richard Silver","Virginia Steen","Charlie Strange","Robert Wise","Fredrick Wigley","Maureen Mayes","David J Riley","Sabiha Hussain","Shervin Assassi","Vivien M Hsu","Bela Patel","Kristine Phillips","Fernando Martinez","Jeffrey Golden","M Kari Connolly","John Varga","Jane Dematte","Monique E Hinchcliff","Aryeh Fischer","Jeffrey Swigris","Richard Meehan","Arthur Theodore","Robert Simms","Suncica Volkov","Dean E Schraufnagel","Mary Beth Scholand","Tracy Frech","Jerry A Molitor","Kristin Highland","Charles A Read","Marvin J Fritzler","Grace Hyun J Kim","Chi-Hong Tseng","Robert M Elashoff","Tashkin, Donald P","Roth, Michael D","Clements, Philip J","Furst, Daniel E","Khanna, Dinesh","Kleerup, Eric C","Goldin, Jonathan","Arriola, Edgar","Volkmann, Elizabeth R","Kafaja, Suzanne","Silver, Richard","Steen, Virginia","Strange, Charlie","Wise, Robert","Wigley, Fredrick","Mayes, Maureen","Riley, David J","Hussain, Sabiha","Assassi, Shervin","Hsu, Vivien M","Patel, Bela","Phillips, Kristine","Martinez, Fernando","Golden, Jeffrey","Connolly, M Kari","Varga, John","Dematte, Jane","Hinchcliff, Monique E","Fischer, Aryeh","Swigris, Jeffrey","Meehan, Richard","Theodore, Arthur","Simms, Robert","Volkov, Suncica","Schraufnagel, Dean E","Scholand, Mary Beth","Frech, Tracy","Molitor, Jerry A","Highland, Kristin","Read, Charles A","Fritzler, Marvin J","Kim, Grace Hyun J","Tseng, Chi-Hong","Elashoff, Robert M",", "],"doi":"10.1016\/s2213-2600(16)30152-7","endpage":"719","first_seen_on":"2016-07-29T18:46:00+00:00","funders":["niehs","nhlbi","niams"],"issns":["2213-2619","22132600"],"issue":"9","journal":"The Lancet Respiratory Medicine","last_mentioned_on":1494007200,"links":["https:\/\/secure.jbs.elsevierhealth.com\/action\/getSharedSiteSession?redirect=http:\/\/www.thelancet.com\/journals\/lanres\/article\/PIIS2213-2600(16)30152-7&rc=0&code=lancet-site","https:\/\/secure.jbs.elsevierhealth.com\/action\/getSharedSiteSession?redirect=http:\/\/www.thelancet.com\/pdfs\/journals\/lanres\/PIIS2213-2600(16)30152-7.pdf&rc=0&code=lancet-site","https:\/\/secure.jbs.elsevierhealth.com\/action\/getSharedSiteSession?redirect=http:\/\/www.thelancet.com\/journals\/lanres\/article\/PIIS2213-2600(16)30152-7\/fulltext?elsca1%3Detoc&rc=0&code=lancet-site","https:\/\/www.ncbi.nlm.nih.gov\/m\/pubmed\/27469583\/","http:\/\/dx.doi.org\/10.1016\/S2213-2600(16)30152-7","http:\/\/www.sciencedirect.com\/science\/article\/pii\/S2213260016301527","http:\/\/www.thelancet.com\/journals\/lanres\/article\/PIIS2213-2600(16)30152-7\/fulltext"],"pdf_url":"http:\/\/www.thelancet.com\/article\/S2213260016301527\/pdf","pmid":"27469583","pubdate":"2016-07-25T00:00:00+00:00","publisher":"Elsevier","startpage":"708","title":"Mycophenolate mofetil versus oral cyclophosphamide in scleroderma-related interstitial lung disease (SLS II): a randomised controlled, double-blind, parallel group trial","type":"article","uri":"http:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213260016301527","volume":"4","mendeley_url":"http:\/\/www.mendeley.com\/research\/mycophenolate-mofetil-versus-oral-cyclophosphamide-sclerodermarelated-interstitial-lung-disease-sls"},"altmetric_score":{"score":25.75,"score_history":{"1y":22.15,"6m":7,"3m":0,"1m":0,"1w":0,"6d":0,"5d":0,"4d":0,"3d":0,"2d":0,"1d":0,"at":25.75},"context_for_score":{"all":{"total_number_of_other_articles":8161014,"mean":6.911576885363,"rank":331375,"this_scored_higher_than_pct":95,"this_scored_higher_than":7829158,"rank_type":"exact","sample_size":8161014,"percentile":95},"similar_age_3m":{"total_number_of_other_articles":257752,"mean":12.02301528219,"rank":18219,"this_scored_higher_than_pct":92,"this_scored_higher_than":239505,"rank_type":"exact","sample_size":257752,"percentile":92},"this_journal":{"total_number_of_other_articles":983,"mean":20.078042769857,"rank":133,"this_scored_higher_than_pct":86,"this_scored_higher_than":850,"rank_type":"exact","sample_size":983,"percentile":86},"similar_age_this_journal_3m":{"total_number_of_other_articles":44,"mean":31.673023255814,"rank":9,"this_scored_higher_than_pct":79,"this_scored_higher_than":35,"rank_type":"exact","sample_size":44,"percentile":79}}},"demographics":{"poster_types":{"member_of_the_public":18,"practitioner":5,"science_communicator":4},"users":{"twitter":{"cohorts":{"Practitioners (doctors, other healthcare professionals)":5,"Members of the public":19,"Science communicators (journalists, bloggers, editors)":3}},"mendeley":{"by_status":{"Unspecified":3,"Professor > Associate Professor":8,"Librarian":1,"Researcher":10,"Student  > Doctoral Student":2,"Student  > Ph. D. Student":7,"Student  > Postgraduate":10,"Other":16,"Student  > Master":6,"Student  > Bachelor":6,"Lecturer":3,"Professor":2},"by_discipline":{"Medicine and Dentistry":62,"Immunology and Microbiology":3,"Agricultural and Biological Sciences":1,"Mathematics":1,"Unspecified":7}}},"geo":{"twitter":{"GD":1,"VE":1,"GB":3,"CA":2,"US":1,"ES":2,"JP":1,"EC":3,"CL":1},"mendeley":{"SG":1,"CA":1,"JP":1,"BR":1,"IT":1,"ES":1}}},"posts":{"f1000":[{"title":"Recommended in F1000 Prime","url":"https:\/\/f1000.com\/prime\/726586187","license":"public","citation_ids":[10121340],"posted_on":"2017-01-13T00:00:00+00:00","f1000_classes":["new_finding"],"f1000_score":"2"}],"twitter":[{"url":"http:\/\/twitter.com\/LancetRespirMed\/statuses\/757962282899038208","license":"gnip","citation_ids":[10121340],"posted_on":"2016-07-26T15:34:25+00:00","author":{"name":"Lancet Respiratory","url":"http:\/\/thelancet.com\/respiratory","image":"https:\/\/pbs.twimg.com\/profile_images\/441604950548697088\/IGKuH0H-_normal.jpeg","description":"A unique and international medical journal for respiratory and critical care specialists.","id_on_source":"LancetRespirMed","tweeter_id":"2375562552","geo":{"lt":null,"ln":null},"followers":5275},"tweet_id":"757962282899038208"},{"url":"http:\/\/twitter.com\/banavarrete\/statuses\/757965127253684225","license":"gnip","rt":["LancetRespirMed"],"citation_ids":[10121340],"posted_on":"2016-07-26T15:45:43+00:00","author":{"name":"Bernardino Alcazar","image":"https:\/\/pbs.twimg.com\/profile_images\/745325783267348480\/8Df2MwvM_normal.jpg","description":"Casado con la mujer de mi vida. Neum\u00f3logo vocacional. Padre de familia muy numerosa","id_on_source":"banavarrete","tweeter_id":"356711852","geo":{"lt":12.11667,"ln":-61.66667,"country":"GD"},"followers":886},"tweet_id":"757965127253684225"},{"url":"http:\/\/twitter.com\/vinitfll\/statuses\/757965322171260930","license":"gnip","rt":["LancetRespirMed"],"citation_ids":[10121340],"posted_on":"2016-07-26T15:46:29+00:00","author":{"name":"Vinicio Tafolla","image":"https:\/\/pbs.twimg.com\/profile_images\/748559997898878976\/32Qzonkb_normal.jpg","description":"Neumologo","id_on_source":"vinitfll","tweeter_id":"3226238276","geo":{"lt":null,"ln":null},"followers":197},"tweet_id":"757965322171260930"},{"url":"http:\/\/twitter.com\/efrasanchez\/statuses\/757968124717268996","license":"gnip","rt":["LancetRespirMed"],"citation_ids":[10121340],"posted_on":"2016-07-26T15:57:37+00:00","author":{"name":"Efra\u00edn J. S\u00e1nchez A.","image":"https:\/\/pbs.twimg.com\/profile_images\/759813071783075841\/rTV4l_kl_normal.jpg","description":"Neumonolog\u00eda Cl\u00ednica. HUC\/UCV- CMDLT\nAn\u00e1lisis de Datos en Ciencias Sociales EE-UCV","id_on_source":"efrasanchez","tweeter_id":"102133975","geo":{"lt":10.48801,"ln":-66.87919,"country":"VE"},"followers":595},"tweet_id":"757968124717268996"},{"url":"http:\/\/twitter.com\/pkell7\/statuses\/757968644735373312","license":"gnip","rt":["LancetRespirMed"],"citation_ids":[10121340],"posted_on":"2016-07-26T15:59:41+00:00","author":{"name":"Patrick Kelly","url":"http:\/\/chiselapp.com\/user\/Entomy","image":"https:\/\/pbs.twimg.com\/profile_images\/789289401197137921\/BcAsGMnr_normal.jpg","description":"Me? I'm madness incarnate.","id_on_source":"pkell7","tweeter_id":"4700259223","geo":{"lt":null,"ln":null},"followers":245},"tweet_id":"757968644735373312"},{"url":"http:\/\/twitter.com\/sarcybint\/statuses\/757971303802494976","license":"gnip","rt":["LancetRespirMed"],"citation_ids":[10121340],"posted_on":"2016-07-26T16:10:15+00:00","author":{"name":"Sara McArthur","image":"https:\/\/pbs.twimg.com\/profile_images\/904329887221248000\/MhDttL_M_normal.jpg","description":"Senior Respiratory physiologist with interests in immunology, allergy, inhaler technique and exercise. Self-professed geek who loves DC, marvel and lego","id_on_source":"sarcybint","tweeter_id":"542840949","geo":{"lt":55.95206,"ln":-3.19648,"country":"GB"},"followers":96},"tweet_id":"757971303802494976"},{"url":"http:\/\/twitter.com\/ild_inn\/statuses\/757998382757605376","license":"gnip","rt":["LancetRespirMed"],"citation_ids":[10121340],"posted_on":"2016-07-26T17:57:52+00:00","author":{"name":"ILD_INN","url":"http:\/\/www.ILD-INN.org.uk","image":"https:\/\/pbs.twimg.com\/profile_images\/649872869770592256\/KhnuyWN1_normal.jpg","description":"A group of ILD health care professionals aiming to provide support, education and influence for the interdisciplinary team & for those in their care with ILD.","id_on_source":"ild_inn","tweeter_id":"3841392556","geo":{"lt":null,"ln":null},"followers":725},"tweet_id":"757998382757605376"},{"url":"http:\/\/twitter.com\/respandsleepjc\/statuses\/761660083621298176","license":"gnip","citation_ids":[10121340],"posted_on":"2016-08-05T20:28:09+00:00","author":{"name":"Resp&Sleep JC #rsjc","url":"http:\/\/sites.utoronto.ca\/respirology\/","image":"https:\/\/pbs.twimg.com\/profile_images\/378800000805839480\/7d22c5b6f937c8ea4d18b99a6ba85a73_normal.jpeg","description":"Asynchronous #rsjc-monthly. Live from UofT resp jc for first few hrs. Views reflect discussion-our own! Eligible for Section 1 Royal College Canada MOC credits!","id_on_source":"respandsleepjc","tweeter_id":"1536628508","geo":{"lt":null,"ln":null},"followers":432},"tweet_id":"761660083621298176"},{"url":"http:\/\/twitter.com\/thelungdr\/statuses\/761660083583475712","license":"gnip","citation_ids":[10121340],"posted_on":"2016-08-05T20:28:09+00:00","author":{"name":"Anju Anand","image":"https:\/\/pbs.twimg.com\/profile_images\/378800000222337666\/b570718ade6eadfe9a06435e3577fa3b_normal.jpeg","description":"Respirologist and Sleep Medicine doctor, mom and travel pro! Toronto, Canada. Views are my own. Moderator & creator of @respandsleepjc","id_on_source":"thelungdr","tweeter_id":"1483766666","geo":{"lt":null,"ln":null},"followers":737},"tweet_id":"761660083583475712"},{"url":"http:\/\/twitter.com\/hswapnil\/statuses\/761660656307154946","license":"gnip","rt":["thelungdr"],"citation_ids":[10121340],"posted_on":"2016-08-05T20:30:26+00:00","author":{"name":"Swapnil Hiremath, MD","url":"http:\/\/about.me\/swapnil.hiremath","image":"https:\/\/pbs.twimg.com\/profile_images\/730502747754139649\/hP6Q9DDQ_normal.jpg","description":"Nephrologist, Mumbai|Boston now Ottawa. #NephJC cofounder. Work at @ottawahospital @uottawamed @ottawarenal Opinions personal etc\/No pharma conflicts","id_on_source":"hswapnil","tweeter_id":"23789628","geo":{"lt":45.41117,"ln":-75.69812,"country":"CA"},"followers":3997},"tweet_id":"761660656307154946"},{"url":"http:\/\/twitter.com\/respandsleepjc\/statuses\/763199752800468992","license":"gnip","citation_ids":[10121340],"posted_on":"2016-08-10T02:26:15+00:00","author":{"name":"Resp&Sleep JC #rsjc","url":"http:\/\/sites.utoronto.ca\/respirology\/","image":"https:\/\/pbs.twimg.com\/profile_images\/378800000805839480\/7d22c5b6f937c8ea4d18b99a6ba85a73_normal.jpeg","description":"Asynchronous #rsjc-monthly. Live from UofT resp jc for first few hrs. Views reflect discussion-our own! Eligible for Section 1 Royal College Canada MOC credits!","id_on_source":"respandsleepjc","tweeter_id":"1536628508","geo":{"lt":null,"ln":null},"followers":432},"tweet_id":"763199752800468992"},{"url":"http:\/\/twitter.com\/thelungdr\/statuses\/763200697127018496","license":"gnip","citation_ids":[10121340],"posted_on":"2016-08-10T02:30:00+00:00","author":{"name":"Anju Anand","image":"https:\/\/pbs.twimg.com\/profile_images\/378800000222337666\/b570718ade6eadfe9a06435e3577fa3b_normal.jpeg","description":"Respirologist and Sleep Medicine doctor, mom and travel pro! Toronto, Canada. Views are my own. Moderator & creator of @respandsleepjc","id_on_source":"thelungdr","tweeter_id":"1483766666","geo":{"lt":null,"ln":null},"followers":737},"tweet_id":"763200697127018496"},{"url":"http:\/\/twitter.com\/GeriMedJC\/statuses\/763203209276059648","license":"gnip","rt":["thelungdr"],"citation_ids":[10121340],"posted_on":"2016-08-10T02:39:59+00:00","author":{"name":"GeriMedJC","url":"http:\/\/gerimedjc.utorontoeit.com\/","image":"https:\/\/pbs.twimg.com\/profile_images\/576938188419121153\/V1ng4moL_normal.png","description":"Geriatric Medicine Journal Club (#GeriMedJC). International engagement around recent literature. Fourth Friday each month. First hour live @uoftmedicine 08:00ET","id_on_source":"GeriMedJC","tweeter_id":"2698894237","geo":{"lt":43.70011,"ln":-79.4163,"country":"CA"},"followers":1427},"tweet_id":"763203209276059648"},{"url":"http:\/\/twitter.com\/GeriMedJC\/statuses\/763203309008195584","license":"gnip","rt":["respandsleepjc"],"citation_ids":[10121340],"posted_on":"2016-08-10T02:40:23+00:00","author":{"name":"GeriMedJC","url":"http:\/\/gerimedjc.utorontoeit.com\/","image":"https:\/\/pbs.twimg.com\/profile_images\/576938188419121153\/V1ng4moL_normal.png","description":"Geriatric Medicine Journal Club (#GeriMedJC). International engagement around recent literature. Fourth Friday each month. First hour live @uoftmedicine 08:00ET","id_on_source":"GeriMedJC","tweeter_id":"2698894237","geo":{"lt":43.70011,"ln":-79.4163,"country":"CA"},"followers":1427},"tweet_id":"763203309008195584"},{"url":"http:\/\/twitter.com\/RheumJC\/statuses\/763209579308212224","license":"gnip","rt":["thelungdr"],"citation_ids":[10121340],"posted_on":"2016-08-10T03:05:18+00:00","author":{"name":"Rheum Journal Club","url":"http:\/\/rheumjc.com","image":"https:\/\/pbs.twimg.com\/profile_images\/687326112372768769\/LKssHTRl_normal.jpg","description":"Rheumatology Journal Club on Twitter: #RheumJC","id_on_source":"RheumJC","tweeter_id":"1201499150","geo":{"lt":null,"ln":null},"followers":2427},"tweet_id":"763209579308212224"},{"url":"http:\/\/twitter.com\/GarchaMed\/statuses\/763221716856295424","license":"gnip","citation_ids":[10121340],"posted_on":"2016-08-10T03:53:31+00:00","author":{"name":"Puneet Garcha","url":"http:\/\/www.baylorhealth.com\/Transplant","image":"https:\/\/pbs.twimg.com\/profile_images\/624796247480623104\/0ueom2Uj_normal.jpg","description":"Transplant Pulmonologist. LHR-PHL-CLE-DFW Tweets reflect my personal opinion.","id_on_source":"GarchaMed","tweeter_id":"941472576","geo":{"lt":32.78306,"ln":-96.80667,"country":"US"},"followers":536},"tweet_id":"763221716856295424"},{"url":"http:\/\/twitter.com\/miguelabad67\/statuses\/763376852287234048","license":"gnip","rt":["LancetRespirMed"],"citation_ids":[10121340],"posted_on":"2016-08-10T14:09:59+00:00","author":{"name":"Miguel Abad","image":"https:\/\/pbs.twimg.com\/profile_images\/876854389570490368\/ozcCM6VM_normal.jpg","description":"Reumatologo. Hospital Virgen Puerto. Plasencia. Siempre  observando y aprendiendo. Mirando siempre hacia delante","id_on_source":"miguelabad67","tweeter_id":"3355367423","geo":{"lt":40.03116,"ln":-6.08845,"country":"ES"},"followers":416},"tweet_id":"763376852287234048"},{"url":"http:\/\/twitter.com\/anafcruz00\/statuses\/763407240539824128","license":"gnip","rt":["LancetRespirMed"],"citation_ids":[10121340],"posted_on":"2016-08-10T16:10:44+00:00","author":{"name":"Ana Cruz Valenciano","image":"https:\/\/pbs.twimg.com\/profile_images\/601862126886596608\/ZS2kbSO4_normal.jpg","id_on_source":"anafcruz00","tweeter_id":"301534921","geo":{"lt":null,"ln":null},"followers":87},"tweet_id":"763407240539824128"},{"url":"http:\/\/twitter.com\/thelungdr\/statuses\/763720440716156928","license":"gnip","rt":["respandsleepjc"],"citation_ids":[10121340],"posted_on":"2016-08-11T12:55:16+00:00","author":{"name":"Anju Anand","image":"https:\/\/pbs.twimg.com\/profile_images\/378800000222337666\/b570718ade6eadfe9a06435e3577fa3b_normal.jpeg","description":"Respirologist and Sleep Medicine doctor, mom and travel pro! Toronto, Canada. Views are my own. Moderator & creator of @respandsleepjc","id_on_source":"thelungdr","tweeter_id":"1483766666","geo":{"lt":null,"ln":null},"followers":737},"tweet_id":"763720440716156928"},{"url":"http:\/\/twitter.com\/DrSimply\/statuses\/764140768827236352","license":"gnip","rt":["thelungdr"],"citation_ids":[10121340],"posted_on":"2016-08-12T16:45:30+00:00","author":{"name":"Rheumatologist","image":"https:\/\/pbs.twimg.com\/profile_images\/877166513882615809\/f9iqdSeU_normal.jpg","description":"Internist-Adult and Pediatric Rheumatologist","id_on_source":"DrSimply","tweeter_id":"621198631","geo":{"lt":null,"ln":null},"followers":2117},"tweet_id":"764140768827236352"},{"url":"http:\/\/twitter.com\/Rheuma_suffolk\/statuses\/769178865126219776","license":"gnip","rt":["LancetRespirMed"],"citation_ids":[10121340],"posted_on":"2016-08-26T14:25:06+00:00","author":{"name":"David OReilly","url":"http:\/\/RheumatologyUK.com","image":"https:\/\/pbs.twimg.com\/profile_images\/829435347591389184\/XE7Eb44r_normal.jpg","description":"\"Distinguished Member\" British Society Rheumatology 2016 Clinics in Suffolk and Cambridge. Early Arthritis -Remission is the mission #RheumatologyUK #Rheumatoid","id_on_source":"Rheuma_suffolk","tweeter_id":"564760857","geo":{"lt":50.76969,"ln":-0.87444,"country":"GB"},"followers":2436},"tweet_id":"769178865126219776"},{"url":"http:\/\/twitter.com\/k_masuko\/statuses\/769179013986123776","license":"gnip","rt":["LancetRespirMed"],"citation_ids":[10121340],"posted_on":"2016-08-26T14:25:42+00:00","author":{"name":"Kayo Masuko MD","url":"http:\/\/community.frontiersin.org\/people\/KayoMasuko\/15104","image":"https:\/\/pbs.twimg.com\/profile_images\/892733112500629504\/qUWLNjwz_normal.jpg","description":"\u5185\u79d1\u533b\u300250\u4ee3\u30fb\u662d\u548c\u751f\u307e\u308c\u3002\u5143\u67d0\u5973\u5b50\u5927\u6559\u6388\u3001\u73fe\u5728\u306f\u533b\u7642\u306b\u623b\u308a\u5185\u79d1\u30fb\u30ea\u30a6\u30de\u30c1\u8a3a\u7642\u3068\u5065\u8a3a\u3002\u307b\u307c\u96d1\u8ac7\u3002TW\u3084RT\u306f\u500b\u4eba\u306e\u898b\u89e3\u3002\u30bc\u30df\u30d6\u30ed\u30b0 http:\/\/msk-zemi.seesaa.net. : Rheumatology & Intern Med. Loves Fine Arts. Tweets R personal.","id_on_source":"k_masuko","tweeter_id":"135697598","geo":{"lt":35.6895,"ln":139.69171,"country":"JP"},"followers":882},"tweet_id":"769179013986123776"},{"url":"http:\/\/twitter.com\/pkiely500\/statuses\/769213793750618113","license":"gnip","rt":["LancetRespirMed"],"citation_ids":[10121340],"posted_on":"2016-08-26T16:43:54+00:00","author":{"name":"Patrick Kiely","image":"https:\/\/pbs.twimg.com\/profile_images\/857656300297232384\/Qzh3dVKn_normal.jpg","description":"Rheumatologist St George's London. Interests biologics for inflammatory arthritis, also myositis and Haemochromatosis. Gardener, fly fisher, 10k & the arts.","id_on_source":"pkiely500","tweeter_id":"741651563161260032","geo":{"lt":51.27358,"ln":-0.43207,"country":"GB"},"followers":287},"tweet_id":"769213793750618113"},{"url":"http:\/\/twitter.com\/IlindelatorreMD\/statuses\/769269352705187841","license":"gnip","citation_ids":[10121340],"posted_on":"2016-08-26T20:24:40+00:00","author":{"name":"Dr Ilin Gilberto dlT","image":"https:\/\/pbs.twimg.com\/profile_images\/836054970407452676\/xjxB0SNL_normal.jpg","description":"M\u00e9dico Internista. Frugal, amante de la lectura y de la tecnolog\u00eda #Internalmedicine Inscitia omnis arrogantiae mater est.","id_on_source":"IlindelatorreMD","tweeter_id":"17943376","geo":{"lt":-2,"ln":-77.5,"country":"EC"},"followers":20317},"tweet_id":"769269352705187841"},{"url":"http:\/\/twitter.com\/sergiobarbaecua\/statuses\/771661169656332288","license":"gnip","citation_ids":[10121340],"posted_on":"2016-09-02T10:48:54+00:00","author":{"name":"Sergio Barba","url":"http:\/\/www.aaaalergia.com","image":"https:\/\/abs.twimg.com\/sticky\/default_profile_images\/default_profile_normal.png","id_on_source":"sergiobarbaecua","tweeter_id":"188846475","geo":{"lt":-0.22985,"ln":-78.52495,"country":"EC"},"followers":62},"tweet_id":"771661169656332288"},{"url":"http:\/\/twitter.com\/reumacia\/statuses\/786962986099412992","license":"gnip","citation_ids":[10121340,8453960],"posted_on":"2016-10-14T16:12:51+00:00","author":{"name":"Cristina Mac\u00eda","url":"https:\/\/goo.gl\/OjfyT8","image":"https:\/\/pbs.twimg.com\/profile_images\/864077813288247296\/uM-hV5ei_normal.jpg","description":"Dra. Cristina Mac\u00eda Villa. Reumat\u00f3loga (Hospital Universitario Severo Ochoa, Madrid). La actualidad reumatol\u00f3gica que quieres saber y no tienes tiempo de buscar","id_on_source":"reumacia","tweeter_id":"2312448956","geo":{"lt":null,"ln":null},"followers":1580},"tweet_id":"786962986099412992"},{"url":"http:\/\/twitter.com\/MedReuma\/statuses\/786971593180405760","license":"gnip","rt":["reumacia"],"citation_ids":[10121340,8453960],"posted_on":"2016-10-14T16:47:03+00:00","author":{"name":"MedReuma","image":"https:\/\/pbs.twimg.com\/profile_images\/885617860327899136\/sEQRMSqz_normal.jpg","description":"Reumat\u00f3loga \ud83c\udde8\ud83c\uddf1 @sochire Soy @panlarLeague Compartiendo la vida con @jmadca #GlutenFree Estos tweets son a t\u00edtulo personal","id_on_source":"MedReuma","tweeter_id":"781947516304719872","geo":{"lt":-30,"ln":-71,"country":"CL"},"followers":718},"tweet_id":"786971593180405760"},{"url":"http:\/\/twitter.com\/Artritis_Celso\/statuses\/787128600776638465","license":"gnip","rt":["reumacia"],"citation_ids":[10121340,8453960],"posted_on":"2016-10-15T03:10:57+00:00","author":{"name":"Dr.Celso Villacreses","url":"http:\/\/care.com.ec","image":"https:\/\/pbs.twimg.com\/profile_images\/1854338247\/x2x1a5g7_normal","description":"M\u00e8dico Cl\u00ednico Reumat\u00f3logo\nEspecializado en Buenos Aires Argentina\nHospital Universitario Jos\u00e8 de San Martin\nUBA.Sociedad Argentina de Reumatolog\u00eda.","id_on_source":"Artritis_Celso","tweeter_id":"493510742","geo":{"lt":-2.20584,"ln":-79.90795,"country":"EC"},"followers":209},"tweet_id":"787128600776638465"},{"url":"http:\/\/twitter.com\/guillem89\/statuses\/801820604332670976","license":"gnip","citation_ids":[10121340],"posted_on":"2016-11-24T16:11:43+00:00","author":{"name":"Guillem Casamayor","image":"https:\/\/pbs.twimg.com\/profile_images\/993542297\/ascensor_normal.jpg","description":"MIR Medicina Interna","id_on_source":"guillem89","tweeter_id":"30282153","geo":{"lt":null,"ln":null},"followers":164},"tweet_id":"801820604332670976"},{"url":"http:\/\/twitter.com\/Aenima666\/statuses\/801820893508931584","license":"gnip","rt":["guillem89"],"citation_ids":[10121340],"posted_on":"2016-11-24T16:12:52+00:00","author":{"name":"Ana Cordob\u00e9s Le\u00f3n","url":"http:\/\/aleaiest.blogspot.com.es\/","image":"https:\/\/pbs.twimg.com\/profile_images\/906600759139205120\/XkTtuVOG_normal.jpg","description":"\ud83d\udd1cBodyfitness Master \ud83d\udcaa\ud83d\udc75\ud83c\udffb \/ \u2692\ud83d\udc8eUnder Construction \/ \ud83d\udcbb\ud83d\udcddBloguera \/ Lupus Warrior \ud83d\udd95\ud83d\udc3a \/ \ud83d\udc9c\ud83d\udd25Unstoppable\ud83d\udd25\ud83d\udc9c #fucklupus Vicepresidenta en #FFpaciente","id_on_source":"Aenima666","tweeter_id":"230754936","geo":{"lt":40.42526,"ln":-3.69063,"country":"ES"},"followers":3895},"tweet_id":"801820893508931584"},{"url":"http:\/\/twitter.com\/UMIPIC\/statuses\/801837006108168192","license":"gnip","rt":["guillem89"],"citation_ids":[10121340],"posted_on":"2016-11-24T17:16:54+00:00","author":{"name":"UMIPIC","image":"https:\/\/pbs.twimg.com\/profile_images\/801461117935620096\/C3qayyJe_normal.jpg","description":"Unidades de Manejo Integral de Paciente con Insuficiencia Card\u00edaca.  Grupo de trabajo Soc. Espa\u00f1ola de Med. Interna.\n#heartfailure\n#nursing\n#medicine #SEMItuit","id_on_source":"UMIPIC","tweeter_id":"733357307627753474","geo":{"lt":null,"ln":null},"followers":438},"tweet_id":"801837006108168192"}],"facebook":[{"url":"https:\/\/www.facebook.com\/permalink.php?story_fbid=1313293748688947&id=566682420016754","license":"public","citation_ids":[10121340],"posted_on":"2016-11-12T12:55:05+00:00","summary":"A 52 year old female patient with anti SCL 70 Progressive Systemic Sclerosis which we follow at our University Hospital clinic as admitted with worsening respiratory symptoms, fatigue and edema.\n She has known sclerodactyly and Interstitial lung disease. N","author":{"name":"Yolanda Farhey MD Rheumatology for Students","url":"https:\/\/www.facebook.com\/566682420016754","facebook_wall_name":"Yolanda Farhey MD Rheumatology for Students","image":"https:\/\/graph.facebook.com\/566682420016754\/picture","id_on_source":"566682420016754"}}],"news":[{"title":"EULAR Update Targets Organ Involvement in Systemic Sclerosis","url":"http:\/\/ct.moreover.com\/?a=30469045879&p=1pl&v=1&x=21Ff1S2bbxtAginUjj6cHQ","license":"public","citation_ids":[1894496,17889605,4023752,7262497,10121340],"posted_on":"2017-05-05T18:00:00+00:00","summary":"Action Points In a systematic review, the European League Against Rheumatism (EULAR) has added two new therapeutic statements addressing organ complications in systemic sclerosis (SSC).","author":{"name":"MedPage Today","url":"http:\/\/www.medpagetoday.com\/","image":"https:\/\/s3.amazonaws.com\/weyland.altmetric.com\/news_sources\/logos\/000\/000\/262\/normal\/Screen_Shot_2016-02-09_at_10.51.03.png?1455015082"}}]}}